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Introduction 
Digital breast tomosynthesis (DBT) when combined with standard 2D digital mammography has 
been shown to improve the performance of breast cancer screening by increasing cancer detection 
rates [1-5].  The 2D component remains an important part of the examination and is used to 
facilitate assessment of symmetry between the breasts, aid comparison with prior mammograms 
and identify the presence of breast microcalcifications where the evidence for detection with DBT is 
less robust [1]. 
The mean glandular dose per view of a DBT image is around 2.3 mGy, which is between 1 - 1.5x 
more than the dose of standard 2D digital mammography [6].  Acquiring both a DBT and standard 2D 
digital mammogram on each woman leads to at least a doubling of the radiation dose, which may 
not be considered acceptable in an asymptomatic screening population.  Consequently there has 
been much interest in the generation of synthetic 2D mammograms from the DBT data set 
eliminating the additional radiation burden of a separate 2D digital mammogram.  
There is evidence from prospective and retrospective studies to support the use of synthetic 2D 
mammograms [5,7-9].  Several retrospective multi-reader studies, including the UK TOMMY trial, 
have demonstrated comparable performance between synthetic and conventional 2D 
mammography [7,8].  The Oslo and Storm-2 prospective studies of DBT in breast cancer screening 
found equivalent cancer detection rates regardless of whether the conventional 2D or the synthetic 
mammograms were read, concluding that synthetic mammograms were an acceptable replacement 
for directly acquired conventional 2D mammograms [5,9].   
Another approach to improve performance is to combine the synthesised image with a Computer 
Aided Detection (CAD) algorithm.  CAD has been used over the years to assist with the interpretation 
of 2D mammography.  CAD software places marks or prompts on the images to draw the reader’s 
attention to potential areas of concern, reducing observational oversights.  A CAD algorithm has 
been developed with machine learning technology (iCAD Inc., Nashua , NH, USA and GE Healthcare, 
Buc, France) to assist in the detection of breast cancer on DBT images.  Unlike a conventional CAD 
system which places marks on the image, areas of concern are automatically identified on each 
tomosynthesis slice and then blended onto a 2D synthetic image to provide a single CAD enhanced 
2D synthetic image for each mammographic projection.  
The aim of this study was to evaluate the diagnostic performance of the CAD enhanced synthetic 
mammogram in comparison with standard 2D synthetic mammograms generated from the DBT data 
set and standard 2D digital mammography. 
 
  
Method:   
The cases were collected as part of a performance study of DBT in the assessment of soft tissue 
screen detected abnormalities in the NHS Breast Screening Programme (NHSBSP).  The study had 
local National Health Service (NHS) Research Ethics committee approval, with all participants giving 
written consent for the use of their images.  68 anonymised cases where raw data was available 
were retrospectively reprocessed by the vendor (GE Healthcare) to produce the CAD enhanced 2D 
synthetic image (Enhanced Volume Preview®).   DBT images were only acquired on the side being 
investigated in the screening recall assessment clinic and so only a single oblique and cranio-caudal 
projection was available for each case.  The original 2D screening mammogram and the standard 
synthetic 2D mammogram generated from the DBT data set (Volume Preview®) were also available 
for the affected side.  DBT imaging was acquired on a commercially available GE Healthcare DBT 
system (SenoClaire®).  The original 2D screening mammograms were performed on GE Healthcare 
full-field digital mammography machines (Senographe Essential®). 
Retrospective reading was performed by two fellowship trained, breast radiologists with 3 and 18 
years breast imaging experience respectively.  Both readers fulfilled NHSBSP Quality Assurance 
Criteria for screening mammography.   Each pair of oblique and cc images (standard 2D, standard 
synthetic 2D and enhanced synthetic 2D) were read separately and independently by each reader.  
Consequently there were 204 pairs of images and the reading order was separately randomised for 
each reader.  The readers were blinded to the final pathology or outcome of assessment for each 
case and the type of image being read.  The readers had no access to the tomosynthesis images used 
to generate the synthetic 2D images.   Each reader assigned an imaging score to each pair of images 
using the UK Royal College of Radiologist 1-5 score [10].  Histopathology provided the ground truth 
outcome for those subjected to biopsy. 
After the scores were assigned, the readers were unblinded and for the cancer cases determined 
whether the correct area had been enhanced by the CAD and the total number of areas enhanced 
on each image, in order to produce a measure of the sensitivity and specificity of the system.   The 
sensitivity was determined by dividing the number of cancers that were correctly marked on the 
oblique or cranio-caudal projections by the total number of cancers.  Specificity in CAD studies is 
traditionally measured by determining the number of false positive marks per image. 
Differences in the performance were assessed using receiver operator characteristic (ROC) analysis.  
The area under the curves (AUC) was compared using Hanley two-tailed test.  P<0.05 was regarded 
as statistically significant. 
 
  
Results 
The study population consisted of 68 cases.  There were 34 malignant cases and 34 normal/benign 
cases.  Of the malignant cases, 31 were invasive carcinoma (91%), two were ductal carcinoma in situ 
(DCIS)(6%) and one a case of aggressive fibromatosis.  Four of the malignant cases had multifocal 
disease and so there were 38 malignant lesions in 34 cases.   
ROC analysis was performed based on the imaging score assigned by each reader to each case 
(Figure 1).  This showed that diagnostic accuracy was significantly improved with the CAD enhanced 
synthetic mammogram compared to the standard synthetic mammogram.  Reader averaged AUC 
were 0.846 and 0.683 respectively (p=0.004).   Diagnostic accuracy was also significantly improved 
with the CAD enhanced synthetic mammogram compared to the conventional 2D mammogram.  
Reader averaged AUC were 0.846 and 0.724 respectively (p=0.027).   There was no significant 
difference in the diagnostic accuracy between the conventional 2D mammogram and standard 
synthetic mammogram.  Reader averaged AUC were 0.723 and 0.683 respectively (p=0.52). 
For the malignant lesions the CAD enhanced synthetic mammogram demonstrated correct 
enhancement of 37 or the 38 lesions - a sensitivity of 97.4% for malignant lesions in this case set.  
The only case that was not enhanced was a 5mm histological grade 1 tubular mixed carcinoma which 
manifested as a 5mm cluster of microcalcifications.  For all 68 cases, there was an average of 3.2 
areas enhanced per image.  For the 34 cancer cases there were 2.1 false areas enhanced per image 
(and 1.1 true areas enhanced per image). 
 
Discussion 
The CAD enhanced synthetic mammogram is a novel approach to improving the performance of the 
2D mammograms synthesised from the DBT data set.  These results show that CAD enhancement 
can improve the diagnostic performance of the synthetic mammogram, potentially achieving a 
performance which is superior to the standard 2D mammogram.  The performance of any synthetic 
mammogram is very dependent on the algorithm used to produce it.  Software which produces 
synthesised 2D mammograms will often undergo multiple re-writes to optimise the image.  In the 
Oslo study DBT screening study an earlier software version yielded a synthesised 2D image where 
the performance was inferior to the conventional 2D mammogram.  Subsequent software 
improvements led to synthetic images which were equivalent to the conventional 2D mammogram 
[9].  CAD enhancement is an alternative software upgrade which also has the potential to improve 
performance of the synthesised mammogram. 
In this study, the performance of the CAD enhanced synthetic mammogram exceeded that of the 
conventional 2D mammogram.  The Oslo DBT study found that some cancers were better 
demonstrated on synthetic mammograms while others were more visible on conventional 2D 
mammography, although they were unable to discern any differences based on breast density, 
grade, size or radiological feature [9].  Zuley et al. performed a retrospective reading study and 
demonstrated that the majority of readers showed a trend for improved performance when reading 
synthetic 2D mammograms alone compared to standard 2D mammograms read alone, although the 
difference was not statistically significant [7].  CAD enhancement uses information from the DBT 
data set to blend onto the synthetic image, so lesions better demonstrated on DBT may be better 
seen with CAD enhancement, which may explain the improved performance compared to the 
standard synthetic image and conventional 2D mammogram.  Phantom studies have suggested that 
synthetic mammograms may be superior for demonstrating high contrast objects, whereas small 
lower contrast lesions such as microcalcificatons can get lost in the background noise of the 
inherently lower resolution synthetic image [11].   
The performance of the CAD enhanced synthetic mammogram seems to be associated with the 
ability of the algorithm to correctly enhance cancers manifesting as soft tissue abnormalities.  In this 
study all but one of the malignant lesions (97.4%) were correctly enhanced.  Images were acquired in 
women undergoing assessment of soft tissue abnormalities so cases where microcalcification was 
the dominant abnormality were not included.  Interestingly the only cancer in this study that was not 
enhanced by the CAD algorithm manifested as a small area of microcalcifications in a patient 
recalled for screening assessment for an asymmetric density that was benign on biopsy.  The CAD 
enhancement algorithm used here is specifically designed to detect soft tissue lesions rather than 
microcalcifications.  This is in marked contrast with traditional prompt based CAD systems used in 
the interpretation of conventional 2D screening mammography which have a high sensitivity for 
detecting microcalcifications, often approaching 100% in some studies [14, 15]. 
The CAD enhancement algorithm produces a large number of falsely enhanced areas on the 
mammogram (2.1 per image).  Studies of traditional CAD used with conventional 2D mammography 
have suggested that the number of false prompts can adversely affect system performance, 
potentially increasing false positive interpretations [12,13].  In addition, a large number of falsely 
placed marks has the potential to distract the reader so that on occasions correctly place marks may 
be overlooked, leading to false negative interpretations [14].  The data presented here in this limited 
retrospective reading study shows no evidence of this, but the case set used was heavily enriched 
with cancers, so prospective evaluation of the algorithm in a representative screening population is 
required. 
Our study has other limitations.  It had a simple design to provide a basic comparison between the 
three different conditions (conventional 2D mammography, standard 2D synthetic mammogram and 
CAD enhanced synthetic mammogram), with the reading order separately randomised for each 
reader.   In reality, synthetic images would always be read in conjunction with the DBT images and 
not in isolation as was undertaken here.  Manufacturers design the synthetic studies to be used as 
guide during the interpretation of the DBT image set, rather than a standalone modality.  Readers 
also had no access to images of the contralateral (normal) breast.   Sometimes it is the lack of 
symmetry between sides which can draw attention to an abnormality.  There is also potential bias 
towards the conventional 2D mammogram because all the abnormalities were originally detected 
and recalled as a result of the conventional 2D screening study.  In addition, the performance of 
synthetic mammography and probably CAD enhancement is highly dependent on the computer 
software and algorithms used to generate the images and so it is difficult to extrapolate the findings 
to different manufacturers’ solutions and software versions. 
Further work is required to determine how best to integrate the CAD enhanced synthetic image into 
the DBT screening workflow.  Although the performance of the CAD enhanced synthetic 
mammogram was superior to the standard synthetic image, it is unclear as to whether the CAD 
enhanced synthetic image is best used as a replacement for the standard synthetic 2D image or 
should be used in a similar fashion to a conventional CAD system, with the areas of CAD 
enhancement being displayed as an overlay to the standard synthetic image at the readers 
discretion.  The latter approach results in the areas of enhancement behaving like traditional CAD 
prompts drawing the reader’s attention to potential areas of concern, with the aim of reducing 
observational oversights. 
In conclusion, CAD enhancement offers an additional approach to further improve the performance 
of synthetic 2D mammography.   Blending information from the DBT data set onto a synthetic image 
has the potential to produce a 2D image which is superior to conventional 2D mammogram for the 
detection of soft tissue breast lesions.  This study adds to the body of evidence that the latest 
software developments should allow synthetic images to replace conventional 2D mammography for 
DBT screening, eliminating the additional radiation burden of a separate conventional 2D 
mammogram.  
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